Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general czech republic population

Journal of Medical Virology

Volumn 86, Issue 9, 2014, Pages 1560-1568

  Šroller, Vojtěch ^a   Hamšíková, Eva ^a   Ludvíková, Viera ^a   Vochozková, Petra ^a   Kojzarová, Martina ^b   Fraiberk, Martin ^b   Saláková, Martina ^a   Morávková, Alena ^b   Forstová, Jitka ^b   Němečková, Šárka ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antibodies; Epidemiology; Polyomavirus; Prevalence

Indexed keywords

PROTEIN VP1; VIRUS ANTIBODY;

ADULT; AGE; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; BK VIRUS; CHILD; CZECH REPUBLIC; FEMALE; HUMAN; HUMAN TISSUE; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MOUSE; NONHUMAN; SEROPREVALENCE; VIRUS LIKE AGENT; VIRUS PURIFICATION; ADOLESCENT; AGE DISTRIBUTION; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL LINE; IMMUNOLOGY; INFANT; INSTITUTE FOR CANCER RESEARCH MOUSE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PRESCHOOL CHILD; TUMOR VIRUS INFECTIONS; VIROLOGY; YOUNG ADULT;

BK POLYOMAVIRUS; MIRIDAE; POLYOMAVIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIBODIES, VIRAL; BK VIRUS; CASE-CONTROL STUDIES; CELL LINE; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; FEMALE; HUMANS; INFANT; JC VIRUS; MALE; MERKEL CELL POLYOMAVIRUS; MICE, INBRED ICR; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; SEROEPIDEMIOLOGIC STUDIES; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 84904052055     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23841     Document Type: Article

References (52)

1. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B. 2007. Identification of a third human polyomavirus. J Virol 81:4130-4136.
2. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pawlita M, Waterboer T, Neale RE. 2010. Prevalence and stability of antibodies to the BK and JC polyomaviruses: A long-term longitudinal study of Australians. J Gen Virol 91:1849-1853.
3. Arora R, Chang Y, Moore PS. 2012. MCV and Merkel cell carcinoma: A molecular success story. Curr Opin Virol 2:489-498.
4. Berger JR. 1988. The neurological complications of HIV infection. Acta Neurol Scand Suppl 116:40-76.
5. Berger JR. 2003. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 9:38-41.
6. Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP. 2009. Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis 15:492-494.
7. Bofill-Mas S, Girones R. 2003. Role of the environment in the transmission of JC virus. J Neurovirol 9:54-58.
8. Bofill-Mas S, Rodriguez-Manzano J, Calgua B, Carratala A, Girones R. 2010. Newly described human polyomaviruses Merkel cell, KI and WU are present in urban sewage and may represent potential environmental contaminants. Virol J 7:141-144.
9. Chen T, Hedman L, Mattila PS, Jartti T, Ruuskanen O, Soderlund-Venermo M, Hedman K. 2011. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 50:125-129.
10. Chesters PM, Heritage J, McCance DJ. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147:676-684.
11. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199:837-846.
12. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
13. Gardner SD, Field AM, Coleman DV, Hulme B. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1:1253-1257.
14. Gardner SD, MacKenzie EF, Smith C, Porter AA. 1984. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 37:578-586.
15. Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch GA, Sloots TP, Wang D. 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathogens 3:e64, 595-604.
16. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. 2002. Bladder carcinoma in a transplant recipient: Evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 73:1933-1936.
17. Gomez BP, Wang C, Viscidi RP, Peng S, He L, Wu TC, Hung CF. 2012. Strategy for eliciting antigen-specific CD8+ T cell-mediated immune response against a cryptic CTL epitope of merkel cell polyomavirus large T antigen. Cell Biosci 2:36-45.
18. Hamilton RS, Gravell M, Major EO. 2000. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 38:105-109.
19. Heritage J, Chesters PM, McCance DJ. 1981. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Virol 8:143-150.
20. Hrbacek J, Urban M, Hamsikova E, Tachezy R, Eis V, Brabec M, Heracek J. 2011. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: A case-control study. BMC Cancer 11:53-62.
21. Imperiale MJ, Major EO. 2007. Polyomaviridae. In: Knipe DM, Howley PM, editors-in-chief: Fields virology, 5th edition. Philadelphia, PA, USA: Lippincott Williams &Wilkins, pp. 2263-2298.
22. Kantola K, Sadeghi M, Lahtinen A, Koskenvuo M, Aaltonen LM, Mottonen M, Rahiala J, Saarinen-Pihkala U, Riikonen P, Jartti T, Ruuskanen O, Soderlund-Venermo M, Hedman K. 2009. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency. J Clin Virol 45:292-295.
23. Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB. 2007. Natalizumab treatment for multiple sclerosis: Recommendations for patient selection and monitoring. Lancet Neurol 6:431-441.
24. Kausman JY, Somers GR, Francis DM, Jones CL. 2004. Association of renal adenocarcinoma and BK virus nephropathy post transplantation. Pediatr Nephrol 19:459-462.
25. Kean JM, Rao S, Wang M, Garcea RL. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathog 5:e1000363, 1-10.
26. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71:115-123.
27. Koljonen V, Kukko H, Pukkala E, Sankila R, Bohling T, Tukiainen E, Sihto H, Joensuu H. 2009. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 101:1444-1447.
28. Kriz B. 2003. Multipurpose serological survey-its philosophy and objectives in the Czech Republic. Cent Eur J Public Health 11:S4-S6.
29. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR. 1999. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 96:7484-7489.
30. Lemos B, Nghiem P. 2007. Merkel cell carcinoma: More deaths but still no pathway to blame. J Invest Dermatol 127:2100-2103.
31. Loyo M, Guerrero-Preston R, Brait M, Hoque MO, Chuang A, Kim MS, Sharma R, Liegeois NJ, Koch WM, Califano JA, Westra WH, Sidransky D. 2010. Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer 126:2991-2996.
32. Nicol JT, Touze A, Robinot R, Arnold F, Mazzoni E, Tognon M, Coursaget P. 2012. Seroprevalence and cross-reactivity of human polyomavirus 9. Emerg Infect Dis 18:1329-1332.
33. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257-1260.
34. Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. 2009. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathogens 5:e1000578.
35. Ramos E, Drachenberg CB, Wali R, Hirsch HH. 2009. The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 87:621-630.
36. Sadeghi M, Riipinen A, Vaisanen E, Chen T, Kantola K, Surcel HM, Karikoski R, Taskinen H, Soderlund-Venermo M, Hedman K. 2010. Newly discovered KI, WU, and Merkel cell polyomaviruses: No evidence of mother-to-fetus transmission. Virol J 7:251-255.
37. Schiller JT, Lowy DR. 2009. Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J Infect Dis 200:166-171.
38. Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. 2010. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7:509-515.
39. Schowalter RM, Pastrana DV, Buck CB. 2011. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathogens 7:e1002161.
40. Scuda N, Hofmann J, Calvignac-Spencer S, Ruprecht K, Liman P, Kuhn J, Hengel H, Ehlers B. 2011. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol 85:4586-4590.
41. Siebrasse EA, Reyes A, Lim ES, Zhao G, Mkakosya RS, Manary MJ, Gordon JI, Wang D. 2012. Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol 86:10321-10326.
42. Smahel M, Sima P, Ludvikova V, Vonka V. 2001. Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Virology 281:231-238.
43. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. 2003. Seroepidemiology of the human polyomaviruses. J Gen Virol 84:1499-1504.
44. Taguchi F, Kajioka J, Miyamura T. 1982. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 26:1057-1064.
45. Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS. 2009. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125:1250-1256.
46. Tolstov YL, Knauer A, Chen JG, Kensler TW, Kingsley LA, Moore PS, Chang Y. 2011. Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis 17:1371-1380.
47. Vallbracht A, Lohler J, Gossmann J, Gluck T, Petersen D, Gerth HJ, Gencic M, Dorries K. 1993. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 143:29-39.
48. van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC. 2010. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathogens 6:e1001024.
49. Viscidi RP, Clayman B. 2006. Serological cross reactivity between polyomavirus capsids. Adv Exp Med Biol 577:73-84.
50. Viscidi RP, Rollison DE, Sondak VK, Silver B, Messina JL, Giuliano AR, Fulp W, Ajidahun A, Rivanera D. 2011. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 18:1737-1743.
51. Zeng Q, Gomez BP, Viscidi RP, Peng S, He L, Ma B, Wu TC, Hung CF. 2012. Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine 30:1322-1329.
52. zur Hausen H. 2008. Novel human polyomaviruses-re-emergence of a well known virus family as possible human carcinogens Int J Cancer 123:247-250.